Skip to main content
. 2020 Feb 10;77(5):1–11. doi: 10.1001/jamaneurol.2019.4992

Table 2. Differences in Primary and Secondary Outcomes Between Groups.

Outcome Measure Time, mo Standard Care Group Palliative Care Intervention Group Difference Between Groupsa
Estimate (95% CI) P Value Estimate (95% CI) P Value Estimate (95% CI) P Value
QOL−AD 6 −0.84 (−1.68 to 0.01) .05 0.66 (−0.43 to 1.75) .23 1.87 (0.47 to 3.27) .009b
12 −0.43 (−1.37 to 0.50) .36 0.68 (−0.38 to 0.73) .21 1.36 (−0.01 to 2.73) .05
QOL−AD caregiver perspective on patient 6 −1.40 (−2.38 to −0.43) .005 2.09 (0.93 to 3.25) <.001 2.82 (1.46 to 4.17) <.001b
12 −0.76 (−1.75 to 0.23) .13 1.81 (0.72 to 2.90) .001 1.93 (0.51 to 3.36) <.001b
ZBI 6 −1.08 (−2.28 to 0.12) .08 −2.28 (−3.38 to −1.18) <.001 −1.62 (−3.32 to 0.09) .06
12 −0.02 (−1.32 to 1.37) .97 −2.25 (−3.56 to −0.94) .001 −2.60 (−4.58 to −0.61) .01b
ESAS−PD 6 −0.45 (−3.86 to 2.96) .80 −6.81 (−10.46 to −3.15) <.001 −7.15 (−11.89 to −2.41) .003b
12 −0.73 (−4.97 to 3.51) .73 −9.66 (−13.52 to −5.80) <.001 −8.27 (−13.90 to −2.64) .004b
PDQ−39 6 −1.20 (−3.57 to 1.18) .23 −3.04 (−5.13 to −0.94) .009 −2.63 (−5.72 to 0.46) .10
12 −0.34 (−2.66 to 1.97) .09 −3.04 (−5.46 to −0.94) .005 −4.05 (−7.25 to −0.84) .01b
UPDRS motor score 6 2.15 (0.04 to 4.27) .05 −2.98 (−5.79 to −0.18) .04 −5.98 (−9.54 to −2.43) .001b
12 2.45 (−0.36 to 5.26) .09 −1.38 (−4.78 to 2.02) .42 −3.91 (−8.38 to 0.56) .09
MOCA 6 −0.14 (−0.82 to 0.55) .69 0.17 (−0.55 to 0.90) .64 0.17 (−0.88 to 1.22) .75
12 −1.05 (−1.78 to −0.32) .005 0.14 (−0.57 to 0.85) .70 1.36 (0.34 to 2.38) .01b
HADS, depression 6 −0.20 (−0.73 to 0.32) .44 −0.34 (−0.97 to 0.30) .29 −0.57 (−1.40 to 0.25) .17
12 0.12 (−0.45 to 0.69) .66 −0.33 (−0.92 to 0.25) .26 −0.52 (−1.33 to 0.29) .21
HADS, anxiety 6 −0.73 (−1.35 to −0.11) .02 −1.19 (−1.71 to −0.68) <.001 −0.66 (−1.44 to 0.13) .13
12 −1.42 (−2.04 to −0.80) <.001 −1.30 (−1.91 to −0.69) <.001 0.12 (−0.71 to 0.95) .78
PG−12 6 −0.68 (−2.05 to 0.68) .32 −2.63 (−3.91 to −1.35) <.001 −2.24 (−4.15 to −0.60) .02
12 −1.31 (−2.73 to 0.11) .07 −2.61 (−3.92 to −1.31) <.001 −1.80 (−3.75 to 0.14) .07
FACIT−SW 6 1.10 (−0.29 to 2.49) .12 1.17 (−0.01 to 2.35) .05 0.71 (−1.12 to 2.55) .44
12 2.30 (0.76 to 3.83) .004 0.61 (−0.83 to 2.04) .40 −1.65 (−3.69 to 0.40) .11
FACIT−SW, meaning 6 0.41 (−0.04 to 0.87) .08 0.23 (−0.26 to 0.71) .36 0.16 (−0.53 to 0.84) .65
12 0.61 (0.08 to 1.14) .02 0.42 (−0.17 to 1.00) .16 −0.00 (−0.77 to 0.77) .99
FACIT−SW, peace 6 0.65 (0.07 to 1.23) .03 0.57 (0.03 to 1.11) .04 0.14 (−0.64 to 0.93) .72
12 1.09 (0.48 to 1.70) .001 0.17 (−0.48 to 0.83) .60 −0.87 (−1.71 to −0.02) .04
FACIT−SW, faith 6 −0.00 (−0.76 to 0.76) .99 0.36 (−0.23 to 0.94) .23 0.50 (−0.48 to 1.48) .32
12 0.53 (−0.19 to 1.24) .15 0.04 (−0.52 to 0.61) .88 −0.54 (−1.46 to 0.38) .25
Patient CGIC 6 −0.46 (−0.72 to −0.19) .001 0.29 (−0.01 to 0.59) .06 0.85 (0.44 to 1.27) <.001b
12 −0.59 (−0.87 to −0.30) <.001 0.41 (0.08 to 0.75) .02 1.21 (0.78 to 1.64) <.001b
Caregiver HADS, depression 6 −0.20 (−0.68 to 0.29) .42 −0.36 (−0.99 to 0.28) .27 −0.49 (−1.32 to 0.34) .25
12 0.47 (−0.17 to 1.12) .15 −0.26 (−0.85 to 0.34) .40 −0.90 (−1.83 to 0.03) .06
Caregiver HADS, anxiety 6 −0.52 (−1.21 to 0.16) .13 −1.21 (−1.90 to −0.52) .001 −1.06 (−2.11 to −0.02) .05
12 −0.40 (−1.13 to 0.34) .29 −0.68 (−1.37 to 0.02) .06 −0.43 (−1.46 to 0.61) .42
Caregiver FACIT−SW 6 −0.27 (−1.42 to 0.89) .65 0.68 (−0.57 to 1.94) .28 1.48 (−0.22 to 3.18) .09
12 −0.90 (−2.12 to 0.31) .14 0.42 (−0.81 to 1.66) .50 1.79 (−0.00 to 3.59) .05
Caregiver FACIT−SW, meaning 6 −0.05 (−0.47 to 0.38) .83 0.03 (−0.37 to 0.42) .90 0.19 (−0.38 to 0.76) .51
12 −0.41 (−0.87 to 0.05) .08 −0.09 (−0.54 to 0.36) .69 0.41 (−0.25 to 1.07) .22
Caregiver FACIT−SW, peace 6 0.11 (−0.56 to 0.78) .75 0.75 (0.15 to 1.34) .01 1.00 (0.12 to 1.88) .03
12 −0.14 (−0.71 to 0.43) .63 0.67 (0.08 to 1.27) .03 1.06 (0.21 to 1.90) .01b
Caregiver FACIT−SW, faith 6 −0.24 (−0.78 to 0.31) .39 −0.09 (−0.74 to 0.56) .78 0.08 (−0.83 to 0.98) .86
12 −0.26 (−0.95 to 0.42) .44 −0.21 (−0.75 to 0.33) .43 0.10 (−0.87 to 1.06) .84
Caregiver CGIC 6 −0.75 (−1.04 to −0.46) <.001 −0.05 (−0.41 to 0.30) .76 0.72 (0.27 to 1.17) .002b
12 −0.81 (−1.11 to −0.50) <.001 0.36 (−0.07 to 0.79) .09 1.20 (0.68 to 1.72) <.001b

Abbreviations: CGIC, Clinical Global Assessment of Change; ESAS−PD, Edmonton Symptom Assessment Scale−Parkinson’s Disease; FACIT−SW, Functional Assessment of Chronic Illness Therapy−Spiritual Wellbeing; HADS, Hospital Anxiety and Depression Scale; MOCA, Montreal Cognitive Assessment; PG−12, Prolonged Grief 12−item scale; QOL−AD, Quality of Life Alzheimer’s Disease scale; UPDRS, Unified Parkinson’s Disease Rating Scale Motor Subscore; ZBI, Zarit Burden Inventory.

a

Treatment effects and P values based on adjusted model.

b

Significant under false discovery rate (α = .05) adjustment for 44 treatment effects.